Dr. Naval Daver, MD
Claim this profileM D Anderson Cancer Center
Expert in Acute Myeloid Leukemia
Expert in T-Lymphoblastic Leukemia/Lymphoma
18 reported clinical trials
26 drugs studied
About Naval Daver, MD
Education:
- Earned an MD from the University of Texas Southwestern Medical Center, Dallas, TX, in 2005.
- Completed Residency in Internal Medicine at Baylor College of Medicine, Houston, TX, from 2005 to 2008.
- Undertook a Fellowship in Hematology/Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX, from 2008 to 2011.
Experience:
- Currently serves as an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.
- Specializes in treating acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN).
Area of expertise
1Acute Myeloid Leukemia
Global LeaderTP53 positive
FLT3 positive
NPM1 positive
2T-Lymphoblastic Leukemia/Lymphoma
Global LeaderTP53 positive
FLT3 positive
NPM1 positive
Affiliated Hospitals
Clinical Trials Naval Daver, MD is currently running
DSP-5336
for Leukemia
This trial is testing a new drug called DSP 5336 to help treat adults with certain types of blood cancer that have come back or didn't respond to previous treatments. The study will first find the best amount to give and then check how safe and helpful it is.
Recruiting1 award Phase 1 & 215 criteria
Ruxolitinib + Azacytidine
for Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm
This trial is testing two drugs, ruxolitinib phosphate and azacytidine, in patients with specific types of blood cancers that are hard to treat. Ruxolitinib blocks enzymes needed for cancer cell growth, while azacytidine kills cancer cells or stops them from dividing. Azacytidine is a well-known anticancer drug used in the treatment of various cancers, including breast cancer, melanoma, and colon cancer. The goal is to find a more effective treatment for these patients.
Recruiting1 award Phase 2
More about Naval Daver, MD
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Naval Daver, MD has experience with
- Azacitidine
- Venetoclax
- IMGN632
- Tuspetinib
- Magrolimab
- Ruxolitinib Phosphate
Breakdown of trials Naval Daver, MD has run
Acute Myeloid Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Naval Daver, MD specialize in?
Naval Daver, MD focuses on Acute Myeloid Leukemia and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Acute Myeloid Leukemia has involved TP53 positive patients, or patients who are FLT3 positive.
Is Naval Daver, MD currently recruiting for clinical trials?
Yes, Naval Daver, MD is currently recruiting for 6 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Naval Daver, MD has studied deeply?
Yes, Naval Daver, MD has studied treatments such as Azacitidine, Venetoclax, IMGN632.
What is the best way to schedule an appointment with Naval Daver, MD?
Apply for one of the trials that Naval Daver, MD is conducting.
What is the office address of Naval Daver, MD?
The office of Naval Daver, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.